Withings, the Paris-based connected health company, has returned to family ownership following the Carreel family’s acquisition of a 90% stake in the organization. The transaction marks a significant shift in the company’s governance structure and represents a renewed commitment to advancing its long-term vision in the connected health sector.
The acquisition reinforces Withings’ independence at a pivotal moment for the company. The timing of the family’s investment coincides with the firm’s announcement of profitability targets for 2025, signaling confidence in the organization’s business trajectory and market position. This development underscores the family’s belief in the company’s strategic direction and operational capabilities.
A Return to Family Leadership
Founded in 2008, Withings has established itself as a notable player in the European healthtech landscape, developing connected devices designed to empower users in managing their health through technology. The Carreel family’s acquisition of controlling interest represents a deliberate choice to guide the company’s future development from a position of substantial ownership.
The move comes as European healthtech companies increasingly seek sustainable business models. Withings’ path toward profitability reflects broader industry trends toward operational efficiency and sustainable growth, particularly among companies that have navigated the competitive dynamics of the consumer health device market.
Strengthening Capacity for Long-Term Vision
By consolidating 90% ownership, the Carreel family has positioned itself to shape Withings’ strategic priorities without significant external constraints. This ownership structure typically provides management with greater flexibility in pursuing long-term objectives rather than optimizing for shorter-term financial returns that external investors might demand.
The company’s focus on connected health—leveraging digital connectivity to enable health monitoring and management—positions it within a sector experiencing sustained interest across Europe. Withings’ product portfolio, which includes connected scales, activity trackers, and health monitoring devices, addresses consumer demand for accessible health technology solutions.
European Healthtech Context
The acquisition reflects broader patterns within the European startup ecosystem, where founders and family-backed entities increasingly seek to retain control of promising ventures. Unlike some regions where venture capital-driven exits dominate, Europe has seen growing momentum among entrepreneurs and founding families choosing to maintain ownership and pursue independent paths to profitability.
This approach has gained traction as companies demonstrate that sustainable profitability can be achieved without requiring traditional venture capital exit scenarios. For healthtech specifically, where regulatory compliance and long-term user trust prove essential, independence and stability may offer strategic advantages that attract both talent and customer confidence in an increasingly crowded market for connected health solutions.